Parkinsonism

Abstract

Parkinsonism is a clinical syndrome, which is characterized by bradykinesia, rigidity, rest tremor, and postural instability. Idiopathic Parkinson disease (PD) is the most common cause of this syndrome, though there are several other important etiologies that must be considered. These include the atypical Parkinsonian disorders multiple system atrophy (MSA), dementia with Lewy Bodies (DLB), progressive supranuclear palsy (PSP), and corticobasal syndrome (CBS); as well as secondary causes of parkinsonism. These various disease entities may be distinguished based on key clinical features, which is critical for the purposes of diagnosis, treatment, and prognosis.

Keywords

Parkinsonism - Parkinson disease - atypical Parkinsonian disorders - Parkinson plus disorders - secondary Parkinsonism

• References

• 1 Roze E, Coêlho-Braga MC, Gayraud D , et al. Head tremor in Parkinson's disease. Mov Disord 2006; 21 (8) 1245-1248
• 2 Ashour R, Tintner R, Jankovic J. Striatal deformities of the hand and foot in Parkinson's disease. Lancet Neurol 2005; 4 (7) 423-431
• 3 Zetusky WJ, Jankovic J, Pirozzolo FJ. The heterogeneity of Parkinson's disease: clinical and prognostic implications. Neurology 1985; 35 (4) 522-526
• 4 Jankovic J, Beach J, Schwartz K, Contant C. Tremor and longevity in relatives of patients with Parkinson's disease, essential tremor, and control subjects. Neurology 1995; 45 (4) 645-648
• 5 Post B, Merkus MP, de Haan RJ, Speelman JD ; CARPA Study Group. Prognostic factors for the progression of Parkinson's disease: a systematic review. Mov Disord 2007; 22 (13) 1839-1851 , quiz 1988
• 6 Fereshtehnejad SM, Romenets SR, Anang JB, Latreille V, Gagnon JF, Postuma RB. New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol 2015; 72 (8) 863-873
• 7 Jankovic J, Schwartz KS, Ondo W. Re-emergent tremor of Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 67 (5) 646-650
• 8 Koller WC. Sensory symptoms in Parkinson's disease. Neurology 1984; 34 (7) 957-959
• 9 Riley D, Lang AE, Blair RD, Birnbaum A, Reid B. Frozen shoulder and other shoulder disturbances in Parkinson's disease. J Neurol Neurosurg Psychiatry 1989; 52 (1) 63-66
• 10 Stamey W, Davidson A, Jankovic J. Shoulder pain: a presenting symptom of Parkinson disease. J Clin Rheumatol 2008; 14 (4) 253-254
• 11 Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 2001; 16 (4) 622-630
• 12 Howell MJ, Schenck CH. Rapid eye movement sleep behavior disorder and neurodegenerative disease. JAMA Neurol 2015; 72 (6) 707-712
• 13 Postuma RB, Aarsland D, Barone P , et al. Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov Disord 2012; 27 (5) 617-626
• 14 Simuni T, Sethi K. Nonmotor manifestations of Parkinson's disease. Ann Neurol 2008; 64 (Suppl. 02) S65-S80
• 15 Gilman S, Wenning GK, Low PA , et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71 (9) 670-676
• 16 Wenning GK, Geser F, Krismer F , et al; European Multiple System Atrophy Study Group. The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 2013; 12 (3) 264-274
• 17 Merlo IM, Occhini A, Pacchetti C, Alfonsi E. Not paralysis, but dystonia causes stridor in multiple system atrophy. Neurology 2002; 58 (4) 649-652
• 18 Jecmenica-Lukic M, Poewe W, Tolosa E, Wenning GK. Premotor signs and symptoms of multiple system atrophy. Lancet Neurol 2012; 11 (4) 361-368
• 19 Klein C, Brown R, Wenning G, Quinn N. The “cold hands sign” in multiple system atrophy. Mov Disord 1997; 12 (4) 514-518
• 20 Massey LA, Micallef C, Paviour DC , et al. Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Mov Disord 2012; 27 (14) 1754-1762
• 21 Brooks DJ, Seppi K ; Neuroimaging Working Group on MSA. Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Mov Disord 2009; 24 (7) 949-964
• 22 Heidebrink JL. Is dementia with Lewy bodies the second most common cause of dementia?. J Geriatr Psychiatry Neurol 2002; 15 (4) 182-187
• 23 McKeith IG, Dickson DW, Lowe J , et al; Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005; 65 (12) 1863-1872
• 24 Collerton D, Burn D, McKeith I, O'Brien J. Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia. Dement Geriatr Cogn Disord 2003; 16 (4) 229-237
• 25 Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum, with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964; 10: 333-359
• 26 Litvan I, Agid Y, Calne D , et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47 (1) 1-9
• 27 Golbe LI. Progressive supranuclear palsy. Semin Neurol 2014; 34 (2) 151-159
• 28 Armstrong MJ, Litvan I, Lang AE , et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 2013; 80 (5) 496-503
• 29 Stamelou M, Alonso-Canovas A, Bhatia KP. Dystonia in corticobasal degeneration: a review of the literature on 404 pathologically proven cases. Mov Disord 2012; 27 (6) 696-702
• 30 Whitwell JL, Jack Jr CR, Boeve BF , et al. Imaging correlates of pathology in corticobasal syndrome. Neurology 2010; 75 (21) 1879-1887
• 31 Curran T, Lang AE. Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses. Mov Disord 1994; 9 (5) 508-520
• 32 Akiguchi I, Ishii M, Watanabe Y , et al. Shunt-responsive parkinsonism and reversible white matter lesions in patients with idiopathic NPH. J Neurol 2008; 255 (9) 1392-1399
• 33 Korczyn AD. Vascular parkinsonism—characteristics, pathogenesis and treatment. Nat Rev Neurol 2015; 11 (6) 319-326
• 34 Vizcarra JA, Lang AE, Sethi KD, Espay AJ. Vascular parkinsonism: deconstructing a syndrome. Mov Disord 2015; 30 (7) 886-894
• 35 Susatia F, Fernandez HH. Drug-induced parkinsonism. Curr Treat Options Neurol 2009; 11 (3) 162-169
• 36 Kim JS, Youn J, Shin H, Cho JW. Nonmotor symptoms in drug-induced parkinsonism and drug-naïve Parkinson disease. Can J Neurol Sci 2013; 40 (1) 36-41